DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Larkin J, Minor D, D'Angelo S. et al.
Overall survival in patients with advanced melanoma who received nivolumab versus investigator’s choice chemotherapy in checkmate 037: A randomized, controlled, open-label phase III trial.
J Clin Oncol 2018;
36: 383-390
Access:
We do not assume any responsibility for the contents of the web pages of other providers.